| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-11 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-10 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |